3 New Strong Buy Ratings from Top-Rated Analysts: 08/04/2026

Wall Street is salivating over these fundamentally sound tickers…

• Workiva (WK): Compliance software leader launches AI agents for growth
• TFI International (TFII): #1 trucking stock with awesome fundamentals
• Insulet (PODD): Diabetes tech leader with up to 118% upside potential

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...

The ONLY AI opportunity you should be looking at

This is the ONLY AI wealth-building opportunity you should be watching right now.

No. It's not about Nvidia, Tesla, or Meta...

It's about one overlooked company profiting off AI "digital goldmines" that are poised to experience 100x growth very soon.

This new opportunity will change the market and make investors a lot of money.

That's why it has received a $500 billion commitment from President Trump himself...

Learn more about this little-known company here >>>

1. Workiva (NYSE: WK)

With the recent launch of specialized AI agents and an intelligence layer, this cloud-based compliance company is advancing its platform capabilities and positioning itself for accelerated growth in the enterprise software space.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $59.80 — get current quote

Max 1-year forecast: $90.00

Why we're watching:

• WK has solid coverage among the analysts we track, with 4 Strong Buy and 1 Buy recommendations. See all recommendations here
• For example, Stifel Nicolaus researcher Brad Reback (a top 12% rated analyst) maintained his Strong Buy recommendation; Stephens & Co. researcher Brett Huff (a top 22% rated analyst) reiterated his Strong Buy with a price target suggesting the stock could see double-digit upside in the coming year. 
• Industry ranking context: WK is currently the #9 highest-rated stock in the App industry, which has an Industry Rating of B.
• Zen Ratings highlights: WK earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks with this rating represent the elite top 5% of all stocks tracked based on a rigorous 115-factor fundamental review.
• Component Grades: WK excels with an A for Growth, reflecting the company's strong expansion trajectory and robust revenue forecasts, while maintaining solid Bs for Financials and Sentiment, a combination that positions it well for continued appreciation. See all 7 Component Grades here

2. TFI International (NYSE: TFII)

This transportation and logistics company has recently captured analyst attention following a strong Q2 performance that beat estimates and demonstrated operational momentum in a challenging freight environment.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $135.02 — get current quote

Max 1-year forecast: $205.00

Why we're watching:

• TFII has strong, bullish coverage among the analysts we track, with 7 Strong Buy, 2 Buy, and 3 Hold recommendations. See all recommendations here
• For example, Citigroup researcher Ariel Rosa (a top 3% rated analyst) maintained his Strong Buy rating with a price target that suggests the stock could see more than 30% upside in the coming year.  
• Six additional top-rated analysts covering TFII include Stephens & Co.'s Bascome Majors, Bank of America's Ken Hoexter, TD Cowen's Jason Seidl, RBC Capital's Walter Spracklin, JP Morgan's Brian Ossenbeck, and Stifel Nicolaus's J. Bruce Chan — all maintaining bullish outlooks on the trucking sector's recovery.
• Industry ranking context: TFII is currently the #1 highest-rated stock in the Trucking industry, which has an Industry Rating of A.
• Zen Ratings highlights: TFII earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
• Component Grades: TFII excels with As for Momentum and Sentiment, reflecting powerful price action and enthusiastic analyst support, while maintaining strong Bs for Growth, Financials, and Safety, a balanced mix that supports both near-term momentum and long-term fundamentals. See all 7 Component Grades here

3. Insulet (NASDAQ: PODD)

Despite recent legal headlines, this insulin-focused medical company's innovative product pipeline and strong market position in diabetes care continue to attract analyst interest and support its long-term growth trajectory.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $165.35 — get current quote

Max 1-year forecast: $360.00

Why we're watching:

• PODD has broad, bullish coverage among the analysts we track, with 9 Strong Buy, 5 Buy, 3 Hold, and 1 Strong Sell recommendations. See all recommendations here
• For example, Leerink Partners researcher Mike Kratky (a top 16% rated analyst) maintained his Buy rating with a price target implying greater than 115% upside potential in the coming year.
• More modest but still quite optimistic, Truist Securities researcher Richard Newitter (a top 13% rated analyst) maintained his Strong Buy with a price target suggesting the stock could see greater than 25% upside in the coming year. 
• Industry ranking context: PODD is currently the #9 highest-rated stock in the Medical Device industry, which has an Industry Rating of C.
• Zen Ratings highlights: PODD earns an overall A rating, equal to a Strong Buy recommendation. This tier represents the top 5% of stocks tracked based on a careful 115-factor fundamental analysis.
• Component Grades: PODD stands out with an A for Financials, reflecting the company's robust profitability and cash flow generation, while maintaining solid Bs for Growth and Value, a combination that supports both expansion potential and reasonable valuation levels. See all 7 Component Grades here

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.